AI Verdict
KAYS has stronger fundamentals based on our AI analysis.
KBLB vs KAYS Fundamental Comparison
| Metric | KBLB | KAYS |
|---|---|---|
| Revenue | $0.0 | $22,557.0 |
| Net Income | $-3.6M | $-12.7M |
| Net Margin | N/A | -56,290.2% |
| ROE | N/A | N/A |
| ROA | -141.2% | -6,369.1% |
| Current Ratio | 0.18x | 0.04x |
| Debt/Equity | N/A | N/A |
| EPS | $0.00 | $-0.16 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KBLB vs KAYS: Frequently Asked Questions
Is KBLB or KAYS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KAYS has stronger fundamentals. KBLB is rated STRONG SELL (95% confidence) while KAYS is rated STRONG SELL (98% confidence). This is not investment advice.
How does KBLB compare to KAYS fundamentally?
Kraig Biocraft Laboratories, Inc. has ROE of N/A vs Kaya Holdings, Inc.'s N/A. Net margins are N/A vs -56,290.2% respectively.
Which stock pays higher dividends, KBLB or KAYS?
KBLB has a dividend yield of N/A or no dividend while KAYS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KBLB or KAYS for long term?
For long-term investing, consider that KBLB has STRONG SELL rating with 95% confidence, while KAYS has STRONG SELL rating with 98% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KBLB vs KAYS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KBLB vs KAYS, the AI consensus favors KAYS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.